These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24434077)

  • 1. Therapeutic effect of anti-αv integrin mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Tomiki H; Kaneyama T; Kobayashi K; Inaba Y; Ichikawa M; Yagita H; Kim BS; Koh CS
    J Neuroimmunol; 2014 Mar; 268(1-2):25-34. PubMed ID: 24434077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of anti-Delta1 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Tsugane S; Takizawa S; Kaneyama T; Ichikawa M; Yagita H; Kim BS; Koh CS
    J Neuroimmunol; 2012 Nov; 252(1-2):66-74. PubMed ID: 22944320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ameliorating effects of anti-Dll4 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Takeichi N; Yanagisawa S; Kaneyama T; Yagita H; Jin YH; Kim BS; Koh CS
    Int Immunol; 2010 Sep; 22(9):729-38. PubMed ID: 20685674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Kaneyama T; Tomiki H; Tsugane S; Inaba Y; Ichikawa M; Akiba H; Yagita H; Kim BS; Koh CS
    Int Immunol; 2014 Jul; 26(7):369-81. PubMed ID: 24486565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Takizawa S; Kaneyama T; Tsugane S; Takeichi N; Yanagisawa S; Ichikawa M; Yagita H; Kim BS; Koh CS
    J Neuroimmunol; 2014 Sep; 274(1-2):78-85. PubMed ID: 25027060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of anti-CD70 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Yanagisawa S; Takeichi N; Kaneyama T; Yagita H; Taniguchi S; Kim BS; Koh CS
    Brain Res; 2010 Mar; 1317():236-45. PubMed ID: 20045400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of α4 integrin in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease: an infectious animal model for multiple sclerosis (MS).
    Hirano Y; Kobayashi K; Tomiki H; Inaba Y; Ichikawa M; Kim BS; Koh CS
    Int Immunol; 2016 Dec; 28(12):575-584. PubMed ID: 27803063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of anti-B7-1 and anti-B7-2 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Inoue A; Koh CS; Yamazaki M; Yagita H
    J Immunol; 1999 Dec; 163(11):6180-6. PubMed ID: 10570309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease.
    Bowen JL; Olson JK
    J Immunol; 2009 Dec; 183(11):6971-80. PubMed ID: 19890055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive effect on Theiler's murine encephalomyelitis virus-induced demyelinating disease by the administration of anti-IL-12 antibody.
    Inoue A; Koh CS; Yamazaki M; Yahikozawa H; Ichikawa M; Yagita H; Kim BS
    J Immunol; 1998 Nov; 161(10):5586-93. PubMed ID: 9820536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and potential role of inducible nitric oxide synthase in the central nervous system of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Iwahashi T; Inoue A; Koh CS; Shin TK; Kim BS
    Cell Immunol; 1999 Jun; 194(2):186-93. PubMed ID: 10383821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice.
    Chang JR; Zaczynska E; Katsetos CD; Platsoucas CD; Oleszak EL
    Virology; 2000 Dec; 278(2):346-60. PubMed ID: 11118358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The innate immune response affects the development of the autoimmune response in Theiler's virus-induced demyelinating disease.
    Olson JK; Miller SD
    J Immunol; 2009 May; 182(9):5712-22. PubMed ID: 19380818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease.
    Neville KL; Dal Canto MC; Bluestone JA; Miller SD
    J Virol; 2000 Sep; 74(18):8349-57. PubMed ID: 10954534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CCL2 treatment inhibits Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Karpus WJ; Kennedy KJ; Fife BT; Bennett JL; Dal Canto MC; Kunkel SL; Lukacs NW
    J Neurovirol; 2006 Aug; 12(4):251-61. PubMed ID: 16966216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response is required for protection from Theiler's virus-induced encephalitis in C57BL/6 mice in the absence of CD8+ T cells.
    Kang BS; Palma JP; Lyman MA; Dal Canto M; Kim BS
    Virology; 2005 Sep; 340(1):84-94. PubMed ID: 16039687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.
    Gilli F; Li L; Pachner AR
    J Neurovirol; 2016 Feb; 22(1):66-79. PubMed ID: 26260496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theiler's Virus-Mediated Immunopathology in the CNS and Heart: Roles of Organ-Specific Cytokine and Lymphatic Responses.
    Omura S; Kawai E; Sato F; Martinez NE; Minagar A; Al-Kofahi M; Yun JW; Cvek U; Trutschl M; Alexander JS; Tsunoda I
    Front Immunol; 2018; 9():2870. PubMed ID: 30619258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR3 signaling is either protective or pathogenic for the development of Theiler's virus-induced demyelinating disease depending on the time of viral infection.
    Jin YH; Kaneyama T; Kang MH; Kang HS; Koh CS; Kim BS
    J Neuroinflammation; 2011 Dec; 8():178. PubMed ID: 22189096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS.
    Richards MH; Getts MT; Podojil JR; Jin YH; Kim BS; Miller SD
    J Autoimmun; 2011 Mar; 36(2):142-54. PubMed ID: 21273044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.